Introduction: Breast Reconstruction and the Challenge of Tissue Ischemia
Breast cancer affects approximately 1 in 8 women and 1 in 800 men in the United States. Modern oncology provides local treatment options (surgery and radiation therapy) and systemic therapies (chemotherapy, hormone therapy, targeted drug therapy, and metabolic therapy). Surgical choices typically range from lumpectomy to full mastectomy.
Following mastectomy, many patients undergo breast reconstruction using autologous tissue flaps and skin grafts to restore a natural appearance. However, tissue transfer carries a risk of inadequate blood supply, resulting in localized ischemia. Without sufficient blood flow, tissue survival is compromised, putting both reconstructive success and aesthetic outcomes at risk.
How Hyperbaric Oxygen Therapy (HBOT) Works
Hyperbaric Oxygen Therapy (HBOT) delivers 100% pure oxygen in a pressurized chamber, significantly increasing the amount of oxygen dissolved directly in the plasma. This hyper-oxygenated state activates multiple biological healing pathways:
•Angiogenesis: Promotes the formation of new blood vessel networks in oxygen-deprived tissues.
•Stem Cell Activation: Stimulates bone marrow stem cell release to accelerate vascular repair.
•Enhanced Mitochondrial Function: Restores cellular ATP energy synthesis in ischemic cells.
•Reperfusion Injury Inhibition: Reduces inflammatory responses and localized edema.
Clinical Evidence: High Flap Survival and Reduced Re-operation Rates
Decades of scientific research validate HBOT as an effective intervention for compromised grafts and flaps:
•Perrins (1966): Early landmark research in the British Journal of Plastic Surgery established the viability of HBOT in preserving skin grafts and flaps.
•Zhou et al. (2014): A meta-analysis of randomized controlled trials reported a flap survival rate of 62.5%–100% with HBOT, compared to only 35%–86.6% in control groups.
•Spruijt et al.: Published in Diving and Hyperbaric Medicine, research showed that using HBOT for ischemic breast flaps avoided the need for additional surgical operations in 58% of cases.
Treatment Workflow & Protocols
•Early intervention is vital when tissue compromise is identified. Plastic surgeons and hyperbaric specialists collaborate closely using diagnostic tools such as Transcutaneous Oxygen Monitoring (TCOM) or Laser Doppler to evaluate tissue perfusion.
•Rapid Referral: Urgent evaluation and initiation of HBOT yield the highest success rates.
•Immediate Response: Noticeable improvement (such as tissue changing from dusky/pale to pinkish) can often be seen after just 1–2 sessions.
•Treatment Duration: Most patients complete 7 to 10 sessions (or approximately 2 weeks of daily therapy) to achieve full vascular recovery and optimal wound healing.
Conclusion
Hyperbaric Oxygen Therapy serves as a valuable, non-invasive adjunctive treatment in post-mastectomy breast reconstruction. By resolving tissue ischemia, stimulating new blood vessel growth, and preventing necrosis, HBOT plays a crucial role in salvaging compromised flaps and skin grafts—helping patients achieve complete physical healing and desirable aesthetic outcomes without secondary surgeries.
References
•Perrins DJD. Hyperbaric oxygenation of skin flaps. Preliminary report. British Journal of Plastic Surgery. 1966;19(2):110-2.
•Zhou. Flap survival rates in HBOT vs control groups. 2014.
•Spruijt NE, Hoekstra LT, Wilmink J, Hoogbergen MH. Hyperbaric oxygen treatment for mastectomy flap ischemia: A case series of 50 breasts. Diving and Hyperbaric Medicine. 2021;51(1):2-9.
•Hyperbaric Oxygen Therapy for Ischemic Complications After Immediate Breast Reconstruction: A Systematic Review and Meta-Analysis. Aesthetic Plastic Surgery. 2026.
•Zhu KJ, Heron MJ, Tiongco RFP, et al. Hyperbaric Oxygen Therapy in Immediate Tissue Expander–Based Breast Reconstruction. Annals of Plastic Surgery. 2025;94(4S):S305-S310.
•Rajpal N, et al. Use of hyperbaric oxygen therapy for tissue ischemia after breast reconstruction. Undersea Hyperbaric Med. 2019.
